发明名称 |
Use of cannabinoids in combination with an anti-psychotic medicament |
摘要 |
The present invention relates to the use of one or more cannabinoids in combination with one or more anti-psychotic medicaments for use in the prevention or treatment of psychosis and psychotic disorders. Preferably the one or more cannabinoids are taken from the group: cannabidiol (CBD); cannabidiolic acid (CBDA); tetrahydrocannbidivarin (THCV); tetrahydrocannbidivarinin acid (THCVA); cannabichromene (CBC); cannabichromenic acid (CBCA); cannabigerol (CBG) and cannabigerolic acid (CBGA). Preferably the anti-psychotic medication is an atypical anti-psychotic medication. |
申请公布号 |
GB2468828(A) |
申请公布日期 |
2010.09.22 |
申请号 |
GB20100012953 |
申请日期 |
2008.12.17 |
申请人 |
GW PHARMA LIMITED;OTSUKA PHARMACEUTICAL CO LIMITED |
发明人 |
TETSURO KIKUCHI;KENJI MAEDA;GEOFFREY GUY;PHILIP ROBSON;COLIN STOTT |
分类号 |
A61K36/185;A61K31/05;A61K31/35;A61K31/352;A61K45/06;A61P25/18;A61P25/22 |
主分类号 |
A61K36/185 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|